|
7735894 ¼±¿µ±â M/71 (RHMÀÌ»ó¿ø/CSÀÌ⿵Pf, Pul¹Ú¹«¼®Pf ÇùÁø )
Churg-strauss Syndrome
Brief Hx
»ó±â 71¼¼ ³²È¯ asthma , sinusitis °ú°Å·ÂÀִ ȯÀÚ·Î ³»¿ø 20ÀÏÀüºÎÅÍÀÇ fever ÁּҷΠŸº´¿øÀÔ¿øÇÏ¿© evaluation ÁøÇàÇÏ¿´À¸³ª,focus ¸íȮġ ¾Ê°í fever Áö¼ÓµÇ¾î 2013.9.2º»¿øÀÔ¿øÇÏ¿´°í,PET-CT»ó RLL mass¼Ò°ßº¸¿© 2013.9.10 wedge resection ½ÃÇà ÈÄ Churg-strauss Syndrome Áø´ÜµÈ ȯÀÚÀÓ.
Smoking Hx :never
1) Asthma (¡Ü) 2) Eosinophils greater than 10% of a differential WBC count3) mononeuropathy or polyneuropathy(¡Ü) 4) Non-fixed pulmonary infiltrates(¡Ü) 5) Presence of paranasal sinus abnormalities(¡Ü) 6) Histological evidence of extravascular eosinophils
** Chest CT (2013.9.3)
Aggravation of diffuse bronchial wall thickening especially in both lower lungs.
Aggravation of bronchial luminal narrowing and nodular infiltrate predominantly in lingular, and BLL.
No change of consolidation/collapse of RML without evidence of endobronchial lesion.
No change of subsegmental consolidation/collapse of RLL medial basal.
Calcified granuloma in left apex.
Multiple small LNs in mediastinum and both hila, probably benign reactive LNs.
No evidence of pleural effusion.
IMP) Aggravated bronchitis and pneumonia in both lungs, r/o airway invasive aspergillosis, ddx) Kaposi sarcoma
** Autoimmune marker (2013.9.24)
MPO(P-ANCA):Positive(29.0), ÀÌ¿Ü All negative
** Pathology: Lung, right lower lobe, wedge resection (2013.9.16)
1. Dense peribronchial and perivascular lymphoplasmacytic infiltration with lymphoid follicles and bronchial wall thickening, consistent with follicular bronchiolitis, see note.
2. Organizing pneumonia
Note) »ó±â Á¶Á÷ÇÐÀû ¼Ò°ßÀº collagen vascular disease, Sjogren`s syndrome, rheumatoid arthritis µî¿¡¼ °üÂûµÉ ¼ö ÀÖ½À´Ï´Ù. Clinical correlationÇϽñ⠹ٶø´Ï´Ù.
** PFT (2013.9.9)
FVC : 2.38L(66%), FEV1 : 1.18L(48 %) ratio : 49%
**PET-CT(2013.9.4)
1. Diffuse bronchial wall thickening with peribronchial infiltrates and nodules in both lungs, predominantly in lower lungs.
2. Nasal mucosal swelling with increased FDG uptake.
3. Subsegmental consolidation/collapse of RML and RLL without definable obstructive lesion.
4. Diffuse FDG uptake in bone marrow and spleen, probably reactive.
5. No other abnormal FDG uptake to suggest malignant process in the rest of imaged body.
Imp. Bronchitis/pneumonia in both lungs, and rhinitis/sinusitis.
DDx. malignant lymphoma.
7120214 ¾çÇö¼÷ F/62 (Pul ¹Ú¹«¼®Pf. / CS ¹è¹Ì°æPf.)
AIP,Pneumonia,interstitial lung disease
Brief Hx
»ó±â 62¼¼ ¿©È¯, ƯÀ̳»°úÀû °ú°Å·Â ¾ø´ø ºÐÀ¸·Î, dizziness, general weakness·Î Ÿº´¿øÀÔ¿ø·ÂÀÖ°í, CxR ¾ÇȼҰߺ¸¿©, º»¿ø ÀǷڵǾî 2013.9.17 ÀÔ¿øÇÏ¿´°í, lung lesion¿¡ ´ëÇÑ Áø´Ü À§ÇÏ¿© 2013.9.25 VATS ½ÃÇà ÈÄ AIP ÀǽɵǾî IV stroid ¹× IV antibiotics À¯ÁöÇÏ¿´À¸³ª ¾ÇÈÁøÇàµÇ¾î 2013.10.4ÀÏ »ç¸ÁÇÑ È¯ÀÚÀÓ.
Smoking Hx :former) -> 10³âÀü quit, 30 ³â * 0.5°©
Á÷¾÷·Â -> ¹Ì¿ë½Ç 45³â , 2³âÀü quit
** Chest CT (2013.9.15):¿ÜºÎ
Subpleural, peribronchial consolidation with subtle GGO in both lungs,
r/o interstitial lung disease such as NSIP. DDx) BOOP less likely.
Several borderline sized LNs in the mediastinum, probably reactive.
Adv) clinical correlation and further f/up.
** Autoimmune marker (2013.9.24)
ANA IFA:1:40+(Speckled), Anti-SS-A/Ro:Positive(62)
ÀÌ¿Ü All negative
** FOB c BAL (2013.9.23)
WBC 430, Mono 90%(macrophage 72%, lymphocyte 18%), PMN 10%, Eosinophils 0%
CD4 66.4%, CD8 19.6% (ratio 3.39)
** Pathology: Lung, right, wedge resection (2013.9.27)
Interstitial organizing fibrosis with hyaline membrane-like fibrinous material, type II pneumocyte hyperplasia and fibroblastic plug in alveolar space, most consistent with proliferative phase of diffuse alveolar damage with areas of organizing pneumonia, see note
D-PAS and GMS special staining reveals no fungal organisms.
5384693 ±è±¹½Â M/68 (Pul ¹Ú¹«¼®Pf. / CS Á¤°æ¿µPf.)
Smoking-related interstitial fibrosis or desquamative interstitial pneumonia
Brief Hx
»ó±â 67¼¼ ³²È¯Àº ƯÀÌ ³»°úÀû °ú°Å·Â ¾ø´ø Áß inspiration ½ÃÀÇ chest pain ÁÖ¼Ò·Î 2013.7.8 º»¿ø ÀÀ±Þ½Ç ³»¿øÇÏ¿© ½ÃÇàÇÑ Chest CT»ó ILD ¼Ò°ß º¸¿© 2013.8.18 º»¿ø È£Èí±â³»°ú ÀÔ¿ø, 2013.8.20 wedge resection under VATS, RLL ½ÃÇàÇÏ¿´À¸¸ç pathology »ó smoking-related interstitial fibrosisÀÇ °¡´É¼ºÀÌ ³ôÀ¸³ª desquamative interstitial pneumonia/respiratory bronchiolitis interstitial lung diseaseÀÇ °¡´É¼ºµµ ¿ÏÀüÈ÷ ¹èÁ¦ÇÒ ¼ö ¾ø´Â ¼Ò°ß º¸ÀÓ. Åð¿ø ÈÄ È£Èí±â³»°ú ¿Ü·¡ f/u ÁßÀÓ.
Èí¿¬·Â : 2.5pack*52yrs= 130PYS, current smoker
Á÷¾÷·Â : ȸ»ç °æ¿µ CEO 40³â - ±¤»ê»ç¾÷ 11³â, °Ç¼³¾÷ 30³â
** Chest CT (2013.7.8)
Traction bronchiectasis, honeycombing, reticular opacities, dominant on the bilateral subpleural area of BLL.
1cm size irregular solid nodule with parenchymal distortion, and calcified nodule in the right apex, probably post inflammatory.
Paraseptal emphysema in BUL.
Diffuse thickening of distal esophageal wall, etiology uncertain.
No pathologically enlarged LNs in mediastinum and hilum.
IMP: 1. rather likely ILD such as UIP.
2. Diffuse esophageal wall thickening, etiology uncertain.
** PFT (2013.7.23)
FVC : 3.40L(85%), FEV1 : 2.60L(94%) ratio : 77% DLCO Adj : 88%, DLCO/VA : 91%
** Autoimmune marker (2013.2.26)
C-ANCA, IFA positive ÀÌ¿Ü All negative
** FOB c BAL (2013.8.19)
WBC 68, Mono 25%(macrophage 19%, lymphocyte 6%), PMN 72%, Eosinophils 3%
CD4 44.8%, CD8 52.6% (ratio 0.85)
**TBLB (2013.3.19) - Chronic non-specific inflammation
** Pathology - Lung, right lower lobe, wedge resection (2013.8.20)
1. Interstitial hyalinized and eosionophilic collagenous fibrosis with lymphoid follicles
2. Emphysematous change
3. Intraalveolar accumulation of pigmented macrophages (smoker's macrophages), see note.
Note) »ý°ËµÈ Á¶Á÷ÀÇ Çö¹Ì°æ ¼Ò°ß°ú ȯÀÚÀÇ °ú°Å·ÂÀ» Á¾ÇÕÇÏ¿© º¼ ¶§ smoking-related interstitial fibrosisÀÇ °¡´É¼ºÀÌ ³ôÀ¸³ª desquamative interstitial pneumonia/respiratory bronchiolitis interstitial lung diseaseÀÇ °¡´É¼ºµµ ¿ÏÀüÈ÷ ¹èÁ¦ÇÒ ¼ö ¾ø½À´Ï´Ù. Clinical correlation ÇϽñ⠹ٶø´Ï´Ù.
5893069 ÇÑ»ó¿ M/70 (Pul ±è¼ÛÀÌPf. / CS ÀÌ⿵Pf.)
Brief Hx
»ó±â 70¼¼ ³²È¯Àº rectal cancer, pT2N1b(2/7)M0 ·Î 2011³â 1¿ùºÎÅÍ 3¿ù±îÁö neoadjuvant CCRTx ½ÃÇà ÈÄ 2011.4.19 LAR ½ÃÇà¹Þ¾ÒÀ¸¸ç 2011³â 8¿ù±îÁö adjuvant RL CTx ½ÃÇà¹Þ¾ÒÀ½. ÀÌÈÄ 2011.4.19 leostomy½ÃÇà ÈÄ Á¾¾ç³»°ú ¿Ü·¡ f/u ÇÏ´ø Áß RULÀÇ two nodules ÀÇ Å©±â Áõ°¡·Î 2012.3 ÈäºÎ¿Ü°ú ÇùÁø ÀǷڵǾî, 2012.3.30 Wedge resection of lung under VATS, RUL ½ÃÇàÇÏ¿´°í pathology »ó Metastatic adenocarcinoma, Chondroid hamartoma ¼Ò°ß º¸ÀÓ. ÀÌÈÄ ¿Ü·¡ f/u ÇÏ´ø Áß 2013.8 Chest CT »óÀÇ subpleural GGO ¿¡ ´ëÇÏ¿© R/O ILD ·Î È£Èí±â³»°ú ÇùÁø ÀǷڵǾú°í ÈäºÎ¿Ü°ú ¿Ü·¡ °æÀ¯ ÀÔ¿øÇÏ¿© 2013.8.23 Wedge resection of RLL under VATS ½ÃÇàÇÏ¿´°í pathology »ó Emphysema¿Í µ¿¹ÝµÈ smoking-related interstitial fibrosis ÀÇ °¡´É¼º °í·ÁÇÏ¿©, ÇöÀç È£Èí±â³»°ú ¿Ü·¡ f/u ÁßÀÓ.
Èí¿¬·Â : 1pack*40yrs=40PYS, Current smoker Á÷¾÷·Â : Á¤¹Ì¼Ò
** Chest CT (2013.8.9)
Compared to prior chest CT of 2013 Ma-7,
No change of subpleural GGO with fine reticulation in both lungs, probably ILD such as NSIP.
However, progression is suggested compared to old chest CTs (from 2011 Jan-7 to 2012 Oct- 29).
No newly developed intrathoracic metastasis.
** PFT (2013.8.20)
FVC : 3.77L(93%), FEV1 : 2.67L(97%) ratio : 71% DLCO Adj : 80%, DLCO/VA : 85%
** Autoimmune marker
ANA IFA (2013.8.13) 1:40+(Speckled)
ANA Titration (2013.9.3) 1:40+,1:160-(Speckled)
** Pathology - Lung, right lower lobe, wedge resection
1. Interstitial hyalinized, ropey, eosionophilic collagenous fibrosis
2. Emphysematous change
3. Intraalveolar accumulation of pigmented macrophages (smoker's macrophages), see note.
Note) Emphysema¿Í µ¿¹ÝµÈ smoking-related interstitial fibrosis ÀÇ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÓ»ó ¼Ò°ß°ú correlation ÇϽñ⠹ٶø´Ï´Ù.
|